1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Adverse Event: new trials by email Literature Review of Adverse Event trials Research Report on Adverse Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intramuscular Ketorolac at Two Single-Dose Regimens Ketorolac Injection 15 mg, Ketorolac Injection 60 mg - Musculoskeletal Pain, Analgesia | Phase 4 | Completed | William Beaumont Army Medical Center | 110 | 2020-06-27 | 2025-10-15 |
Agnosia (1) · Emergencies (1) · Musculoskeletal Pain (1)
Disease Attributes (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Perceptual Disorders (1) · Signs and Symptoms (1)
Ketorolac (1) · Ketorolac Tromethamine (1)
William Beaumont Army Medical Center (1)
United States (1)